Can-Fite BioPharma Ltd.
(CANF)
undefined
undefined%
At close: undefined
1.58
-0.32%
After-hours Dec 13, 2024, 07:33 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
Revenue | 743.00K | 810.00K | 853.00K | 763.00K | 2.03M | 3.82M | 844.75K | 169.50K | 164.72K | - | 1.78M | - | 469.00K | 745.21K |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 743.00K | 810.00K | 853.00K | 763.00K | 2.03M | 3.82M | 844.75K | 169.50K | 164.72K | - | 1.78M | - | 469.00K | 745.21K |
Operating Income | -8.20M | -10.10M | -12.84M | -14.14M | -12.01M | -5.41M | -7.38M | -8.63M | -6.42M | -7.13M | -8.99M | -5.99M | -4.78M | -3.76M |
Interest Income | 506.00K | 222.00K | 24.00K | 44.00K | 72.00K | 51.00K | 2.99M | 88.91K | 1.92M | 11.56K | 26.42K | 13.38K | 438.52K | 31.00K |
Pretax Income | -7.63M | -10.17M | -12.62M | -14.44M | -12.63M | -6.57M | -4.95M | -6.99M | -5.06M | -6.29M | -8.85M | -5.86M | -7.42M | -3.61M |
Net Income | -7.63M | -10.17M | -12.62M | -14.44M | -12.63M | -6.57M | -6.34M | -8.26M | -6.24M | -6.10M | -8.38M | -5.59M | -6.70M | -3.68M |
Selling & General & Admin | 2.96M | 3.14M | 3.85M | 2.95M | 3.06M | 3.16M | 2.95M | 2.70M | 2.70M | 2.94M | 4.52M | 2.48M | 1.86M | 1.69M |
Research & Development | 5.98M | 7.76M | 9.85M | 11.95M | 10.98M | 6.08M | 5.27M | 6.08M | 3.86M | 4.16M | 4.42M | 3.52M | 3.41M | 2.82M |
Other Expenses | - | - | - | - | - | - | - | - | - | -20.64M | - | - | - | - |
Operating Expenses | 8.94M | 10.91M | 13.70M | 14.90M | 14.04M | 9.23M | 8.22M | 8.80M | 6.58M | 7.13M | 8.99M | 6.00M | 5.27M | 4.51M |
Interest Expense | 14.00K | 63.00K | 22.00K | 363.00K | 427.00K | 1.20M | 1.10M | 27.30K | 564.34K | 14.89K | 16.08K | 7.23K | 60.96K | 7.33K |
Selling & Marketing Expenses | - | - | - | - | - | - | 31.07K | - | - | - | - | 42.70K | - | - |
Cost & Expenses | 8.94M | 10.91M | 13.70M | 14.90M | 14.04M | 9.23M | 8.22M | 8.80M | 6.58M | 7.13M | 8.99M | 6.00M | 5.27M | 4.51M |
Income Tax | - | 63.00K | -20.00K | 363.00K | 427.00K | 4.00K | 29.92K | 29.12K | 4.35K | 5.91K | 2.58K | 2.94K | 50.18K | 66.23K |
Shares Outstanding (Basic) | 4.26M | 815.80M | 458.88M | 341.51M | 85.91M | 38.90M | 32.53M | 27.69M | 22.95M | 17.55M | 13.71M | 10.05M | 31.18K | 28.96K |
Shares Outstanding (Diluted) | 4.26M | 815.75M | 553.08M | 358.41M | 85.91M | 38.90M | 32.53M | 27.69M | 22.95M | 17.55M | 13.71M | 10.05M | 31.18K | 28.96K |
EPS (Basic) | -1.79 | -0.01 | -0.03 | -0.04 | -0.15 | -0.17 | -0.19 | -0.3 | -0.27 | -0.35 | -0.61 | -0.56 | -214.89 | -127 |
EPS (Diluted) | -1.79 | -0.01 | -0.02 | -0.04 | -0.15 | -0.17 | -0.19 | -0.3 | -0.27 | -0.35 | -0.61 | -0.56 | -214.89 | -127 |
EBITDA | -8.18M | -10.08M | -12.83M | -14.13M | -11.99M | -6.54M | -6.36M | -8.68M | -5.05M | -6.82M | -8.52M | -5.65M | -7.83M | -3.36M |
Depreciation & Amortization | 15.00K | 14.00K | 14.00K | 12.00K | 14.00K | 14.00K | 19.00K | 18.50K | 16.39K | 12.07K | 16.65K | 23.02K | 57.28K | 78.64K |